Exencial Wealth Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Buy |
47,705
+809
| +2% | +$31.1K | 0.06% | 222 |
|
|
2025
Q1 | $1.82M | Buy |
46,896
+1,028
| +2% | +$39.8K | 0.07% | 225 |
|
|
2024
Q4 | $1.55M | Sell |
45,868
-3,070
| -6% | -$104K | 0.06% | 243 |
|
|
2024
Q3 | $2M | Buy |
48,938
+321
| +0.7% | +$13.1K | 0.07% | 213 |
|
|
2024
Q2 | $1.87M | Sell |
48,617
-2,262
| -4% | -$87.1K | 0.07% | 210 |
|
|
2024
Q1 | $2.18M | Sell |
50,879
-2,109
| -4% | -$90.4K | 0.08% | 201 |
|
|
2023
Q4 | $1.96M | Buy |
52,988
+491
| +0.9% | +$18.2K | 0.08% | 194 |
|
|
2023
Q3 | $1.9M | Sell |
52,497
-3,589
| -6% | -$130K | 0.09% | 179 |
|
|
2023
Q2 | $2M | Buy |
56,086
+16,931
| +43% | +$603K | 0.09% | 182 |
|
|
2023
Q1 | $1.39M | Sell |
39,155
-4,191
| -10% | -$149K | 0.07% | 196 |
|
|
2022
Q4 | $1.52M | Sell |
43,346
-1,797
| -4% | -$63.1K | 0.08% | 190 |
|
|
2022
Q3 | $1.33M | Sell |
45,143
-1,719
| -4% | -$50.6K | 0.08% | 189 |
|
|
2022
Q2 | $2.55M | Buy |
46,862
+662
| +1% | +$36K | 0.14% | 154 |
|
|
2022
Q1 | $2.52M | Buy |
46,200
+2,422
| +6% | +$132K | 0.13% | 168 |
|
|
2021
Q4 | $2.41M | Buy |
43,778
+2,112
| +5% | +$116K | 0.12% | 175 |
|
|
2021
Q3 | $1.99M | Buy |
41,666
+1,585
| +4% | +$75.7K | 0.09% | 150 |
|
|
2021
Q2 | $2M | Buy |
40,081
+4,071
| +11% | +$203K | 0.11% | 176 |
|
|
2021
Q1 | $1.61M | Sell |
36,010
-3,160
| -8% | -$141K | 0.1% | 185 |
|
|
2020
Q4 | $1.8M | Sell |
39,170
-40,893
| -51% | -$1.88M | 0.12% | 159 |
|
|
2020
Q3 | $3.77M | Buy |
80,063
+39,281
| +96% | +$1.85M | 0.2% | 133 |
|
|
2020
Q2 | $2.08M | Buy |
+40,782
| New | +$2.08M | 0.18% | 138 |
|